Expression of a novel human apolipoprotein (apoC-IV) causes hypertriglyceridemia in transgenic mice

Journal of Lipid Research

Volumn 37, Issue 7, 1996, Pages 1510-1518

  Allan, Charles M ^a,b   Taylor, John M ^a,b  

^a GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

apolipoprotein C IV; plasma lipoprotein; transgene; triglyceride

Indexed keywords

APOLIPOPROTEIN C; LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; GENE EXPRESSION; GLYCOSYLATION; HYPERTRIGLYCERIDEMIA; IMMUNOBLOTTING; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SIALYLATION; TRANSGENIC MOUSE;

ANIMALS; APOLIPOPROTEINS C; CHOLESTEROL; DNA, COMPLEMENTARY; HUMANS; HYPERTRIGLYCERIDEMIA; LIPOPROTEINS, VLDL; LIVER; MICE; MICE, TRANSGENIC; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRIGLYCERIDES;

EID: 0029891752     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Smit, M., E. van der Kooij-Meijs, R. R. Frants, L. Havekes, and E. C. Klasen. 1988. Apolipoprotein gene cluster on chromosome 19. Definite localization of the APOC2 gene and the polymorphic HpaI site associated with type III hyperlipoproteinemia. Hum. Genet. 78: 90-93.
2. Myklebost, O., and S. Rogne. 1988. A physical map of the apolipoprotein gene cluster on human chromosome 19. Hum. Genet. 78: 244-247.
3. Lauer, S. J., D. Walker, N. A. Elshourbagy, C. A. Reardon, B. Levy-Wilson, and J. M. Taylor. 1988. Two copies of the human apolipoprotein C-I gene are linked closely to the apolipoprotein E gene. J. Biol. Chem. 263: 7277-7286.
4. Li, W-H., M. Tanimura, C-C. Luo, S. Datta, and L. Chan. 1988. The apolipoprotein multigene family: biosynthesis, structure, structure-function relationships, and evolution. J. Lipid Res. 29: 245-271.
5. Elshourbagy, N. A., D. W. Walker, M. S. Boguski, J. I. Gordon, and J. M. Taylor. 1986. The nucleotide and derived amino acid sequence of human apolipoprotein A-IV mRNA and the close linkage of its gene to the genes of apolipoproteins A-I and C-III. J. Biol. Chem. 261: 1998-2002.
6. Protter, A. A., B. Levy-Wilson, J. Miller, G. Bencen, T. White, and J. J. Seilhamer. 1984. Isolation and sequence analysis of the human apolipoproteinCIII gene and the intergenic region between the apoAI and apoCIII genes. DNA. 3: 449-456.
7. Allan, C. M., D. Walker, J. P. Segrest, and J. M. Taylor. 1995. Identification and characterization of a new human gene (APOC4) in the apolipoprotein E, C-I, and C-II gene locus. Genomics. 28: 291-300.
8. Brown, M. S., and J. L. Goldstein. 1986. A receptor-mediated pathway for cholesterol homeostasis. Science. 232: 34-47.
9. Mahley, R. W., and T. L. Innerarity. 1983. Lipoprotein receptors and cholesterol homeostasis. Biochim. Biophys. Acta. 737: 197-222.
10. Beisiegel, U., W. Weber, G. Ihrke, J. Herz, and K. K. Stanley. 1989. The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature. 341: 162-164.
11. Ji, Z-S., S. Fazio, Y-L. Lee, and R. W. Mahley. 1994. Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans. J. Biol. Chem. 269: 2764-2772.
12. Breckenridge, W. C., J. A. Little, G. Steiner, A. Chow, and M. Poapst. 1978. Hypertriglyceridemia associated with deficiency of apolipoprotein C-II. N. Engl. J. Med. 298: 1265-1273.
13. Sehayek, E., and S. Eisenberg. 1991. Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway. J. Biol. Chem. 266: 18259-18267.
14. Weisgraber, K. H., R. W. Mahley, R. C. Kowal, J. Herz, J. L. Goldstein, and M. S. Brown. 1990. Apolipoprotein C-I modulates the interaction of apolipoprotein E with β-migrating very low density lipoproteins (β-VLDL) and inhibits binding of β-VLDL to low density lipoprotein receptor-related protein. J. Biol. Chem. 265: 22453-22459.
15. Anantharamaiah, G. M., M. K. Jones, and J. P. Segrest. 1993. An atlas of the amphipathic helical domains of human exchangeable plasma apolipoproteins. In The Amphipathic Helix. R. M. Epand, editor. CRC Press, Boca Raton, FL. 109-142.
16. Aalto-Setälä, K., E. A. Fisher, X. Chen, T. Chajek-Shaul, T. Hayek, R. Zechner, A. Walsh, R. Ramakrishnan, H. N. Ginsberg, and J. L. Breslow. 1992. Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apoCIII and reduced apoE on the particles. J. Clin. Invest. 90: 1889-1900.
17. de Silva, H. V., S. J. Lauer, J. Wang, W. S. Simonet, K. H. Weisgraber, R. W. Mahley, and J. M. Taylor. 1994. Overexpression of human apolipoprotein C-III in transgenic mice results in an accumulation of apolipoprotein B48 remnants that is corrected by excess apolipoprotein E. J. Biol. Chem. 269: 2324-2335.
18. Shachter, N. S., T. Hayek, T. Leff, J. D. Smith, D. W. Rosenberg, A. Walsh, R. Ramakrishnan, I. J. Goldberg, H. N. Ginsberg, and J. L. Breslow. 1994. Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic mice. J. Clin. Invest. 93: 1683-1690.
19. Simonet, W. S., N. Bucay, R. E. Pitas, S. J. Lauer, and J. M. Taylor. 1991. Multiple tissue-specific elements control the apolipoprotein E/C-I gene locus in transgenic mice. J. Biol. Chem. 266: 8651-8654.
20. Fan, J., J. Wang, A. Bensadoun, S. J. Lauer, Q. Dang, R. W. Mahley, and J. M. Taylor. 1994. Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proc. Natl. Acad. Sci. USA. 91: 8724-8728.
21. Simonet, W. S., N. Bucay, S. J. Lauer, and J. M. Taylor. 1993. A far-downstream hepatocyte-specific control region directs expression of the linked human apolipoprotein E and C-I genes in transgenic mice. J. Biol. Chem. 268: 8221-8229.
22. Simonet, W. S., N. Bucay, S. J. Lauer, D. O. Wirak, M. E. Stevens, K. H. Weisgraber, R. E. Pitas, and J. M. Taylor. 1990. In the absence of a downstream element, the apolipoprotein E gene is expressed at high levels in kidneys of transgenic mice. J. Biol. Chem. 265: 10809-10812.
23. MacDonald, R. J., G. H. Swift, A. E. Przybyla, and J. M. Chirgwin. 1987. Isolation of RNA using guanidinium salts. Methods Enzymol. 152: 219-227.
24. Gilman, M. 1993. Ribonuclease protection assay. In Current Protocols in Molecular Biology. Vol. 1. F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl, editors. John Wiley & Sons, New York. 4.7.1-4.7.8.
25. de Silva, H. V., J. Más-Oliva, J. M. Taylor, and R. W. Mahley. 1994. Identification of apolipoprotein B-100 low density lipoproteins, apolipoprotein B-48 remnants, and apolipoprotein E-rich high density lipoproteins in the mouse. J. Lipid Res. 35: 1297-1310.
26. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci USA. 76: 4350-4354.
27. Yamanaka, S., M. E. Balestra, L. D. Ferrell, J. Fan, K. S. Arnold, S. Taylor, J. M. Taylor, and T. L. Innerarity. 1995. Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc. Natl. Acad. Sci. USA. 92: 8483-8487.
28. Allan, C. M., N. H. Fidge, and J. Kanellos. 1992. Antibodies to the carboxyl terminus of human apolipoprotein A-I. The putative cellular binding domain of high density lipoprotein 3 and carboxyl-terminal structural homology between apolipoprotein A-I and A-II. J. Biol. Chem. 267: 13257-13261.
29. Curtiss, L. K., and R. S. Smith. 1988. Localization of two epitopes of apolipoprotein A-I that are exposed on human high density lipoproteins using monoclonal antibodies and synthetic peptides. J. Biol. Chem. 263: 13779-13785.
30. Wernette-Hammond, M. E., S. J. Lauer, A. Corsini, D. Walker, J. M. Taylor, and S. C. Rall, Jr. 1989. Glycosylation of human apolipoprotein E. The carbohydrate attachment site is threonine 194. J. Biol. Chem. 264: 9094-9101.
31. Vaith, P., G. Assmann, and G. Uhlenbruck. 1978. Characterization of the oligosaccharide side chain of apolipoprotein C-III from human plasma very low density lipoproteins. Biochim. Biophys. Acta. 541: 234-240.
32. Swaney, J. B., and K. H. Weisgraber. 1994. Effect of apolipoprotein C-I peptides on the apolipoprotein E content and receptor-binding properties of beta-migrating very low density lipoproteins. J. Lipid Res. 35: 134-142.
33. 1-fetoprotein locus. J. Biol. Chem. 269: 5481-5484.
34. Peschle, C., F. Mavilio, A. Carè, G. Migliaccio, A. R. Migliaccio, G. Salvo, P. Samoggia, S. Petti, R. Guerriero, M. Marinucci, D. Lazzaro, G. Russo, and G. Mastroberardino. 1985. Haemoglobin switching in human embryos: asynchrony of ζ→α and ε→γ-globin switches in primitive and definitive erythropoietic lineage. Nature. 313: 235-238.
35. Hardardóttir, I., S. T. Kunitake, A. H. Moser, W. T. Doerrler, J. H. Rapp, C. Grünfeld, and K. R. Feingold. 1994. Endotoxin and cytokines increase hepatic messenger RNA levels and serum concentrations of apolipoprotein J (clusterin) in Syrian hamsters. J. Clin. Invest. 94: 1304-1309.
36. Hoffman, J. S., and E. P. Benditt. 1982. Secretion of serum amyloid protein and assembly of serum amyloid protein-rich high density lipoprotein in primary mouse hepatocyte culture. J. Biol. Chem. 257: 10518-10522.
37. Morrissey, J. H. 1981. Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity. Anal. Biochem. 117: 307-310.